Another Reglan lawsuit has been filed in the Superior Court of California on June 16, 2012 over the drug’s tardive dyskinesia (TD) side effects. In the lawsuit, the plaintiff claims that she was prescribed the drug for longer than the approved time period — that she took Reglan from 2007-2009 as directed by her doctor — and that as a result of her prolonged use, she says that she suffers from TD. TD is a permanent neurological condition that causes sufferers to experience involuntary movements of the extremities, lip smacking, grimacing and eye blinking.
The damages the plaintiff suffered from has caused her to ask for “relief for medical expenses, loss of the ability to provide household services, disfigurement, disability, pain and suffering, psychological injury and other injuries and damages.”
Like numerous other Reglan TD lawsuits, the plaintiff in this case is blaming Wyeth, Pfizer and other pharmaceutical defendants for her injuries because she claims that they didn’t properly warn her of the dangers linked to long-term use of Reglan before she started taking the drug. Under the terms of her lawsuit, the claimant is specifically accusing the manufacturers of Reglan of “strict liability, negligence, fraud, breach of implied warranties and other statutory claims.”
Reglan has been on the market since 1996 and is used to treat acid reflux and gastroesophogeal reflux disease (GERD). Even though the drug isn’t supposed to be used for longer than 112 weeks, many doctors have prescribed the drug for weeks, months and even years at a time. It is for this reason that plaintiffs have started filing lawsuits. Thousands of patients have sued the manufacturers of Reglan over TD and other side effects, and this has caused the FDA to force the manufacturers to update the drug’s warning labels to include the dangers of prolonged use.
